Anand Iyer, PhD, MBA, is the chief AI officer at Welldoc, a global leader in digital health innovation. A pioneer in the integration of AI, digital therapeutics, and mobile health, he played a central role in developing BlueStar®, the first FDA-cleared digital therapeutic for adults with type 2 diabetes. Since joining Welldoc in 2008, he has served in multiple leadership roles, including president, COO, and chief strategy officer, and has previously been recognized as Maryland Healthcare Innovator of the Year and as a global thought leader on Constellation Research’s AI 150 list.

With a career spanning technology, strategy, and regulatory policy, Dr. Iyer previously directed PRTM’s wireless consulting practice, helping global firms harness disruptive technologies and new business models. He co-founded the Digital Therapeutics Alliance, founded the In-Building Wireless Alliance, and teaches advanced wireless technologies to senior officers in the U.S. Department of Defense at the Institute for Defense and Business. He holds a PhD and MS in electrical and computer engineering and an MBA from Carnegie Mellon University.